HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis

Astract Glioblastoma multiforme (GBM) is one of the most aggressive forms of brain cancer, characterized by rapid growth and resistance to conventional therapies. This study investigates the role of HADHA, a key enzyme in fatty acid β-oxidation, in the progression of GBM. we show that the overexpres...

Full description

Saved in:
Bibliographic Details
Main Authors: Kan Wang, Yifei Xiao, Jinxin Wan, Yuanqi Chu, Ruipeng Zheng, Fengjun Lv, Guang Yang, Mingchun Yang, Haitao Ge, Yuwen Song, Yu Cheng
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02660-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849767231384190976
author Kan Wang
Yifei Xiao
Jinxin Wan
Yuanqi Chu
Ruipeng Zheng
Fengjun Lv
Guang Yang
Mingchun Yang
Haitao Ge
Yuwen Song
Yu Cheng
author_facet Kan Wang
Yifei Xiao
Jinxin Wan
Yuanqi Chu
Ruipeng Zheng
Fengjun Lv
Guang Yang
Mingchun Yang
Haitao Ge
Yuwen Song
Yu Cheng
author_sort Kan Wang
collection DOAJ
description Astract Glioblastoma multiforme (GBM) is one of the most aggressive forms of brain cancer, characterized by rapid growth and resistance to conventional therapies. This study investigates the role of HADHA, a key enzyme in fatty acid β-oxidation, in the progression of GBM. we show that the overexpression of HADHA in GBM correlates with a poor prognosis in patients and plays a role in promoting tumor growth and invasion. Mechanistically, HADHA regulates the JAK/STAT3 signaling pathway through modulation of H3K27ac histone acetylation. Knockdown of HADHA results in decreased acetyl-CoA levels, leading to reduced H3K27ac modification and subsequent inhibition of JAK/STAT3 activation. Furthermore, we show that the small molecule JIB-04, which targets HADHA, inhibits GBM cell proliferation and invasion both in vitro and in vivo. Our findings highlight the importance of targeting metabolic enzymes in cancer therapy and suggest that HADHA could represent a potential new therapeutic target for GBM. By targeting the metabolic-epigenetic pathway, this strategy presents a promising approach for treating this devastating disorder.
format Article
id doaj-art-97a218776c744c44a08dbeedf30f3ed4
institution DOAJ
issn 2058-7716
language English
publishDate 2025-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-97a218776c744c44a08dbeedf30f3ed42025-08-20T03:04:17ZengNature Publishing GroupCell Death Discovery2058-77162025-08-0111111210.1038/s41420-025-02660-0HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axisKan Wang0Yifei Xiao1Jinxin Wan2Yuanqi Chu3Ruipeng Zheng4Fengjun Lv5Guang Yang6Mingchun Yang7Haitao Ge8Yuwen Song9Yu Cheng10Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, Guangdong Provincial People’s Hospital, Zhuhai Hospital (Jinwan Central Hospital of Zhuhai)Department of Pathology, XD Group hospitalDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, The Second Affiliated Hospital of Fujian Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityDepartment of neurosurgery, The Fourth Affiliated Hospital of Harbin Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical UniversityAstract Glioblastoma multiforme (GBM) is one of the most aggressive forms of brain cancer, characterized by rapid growth and resistance to conventional therapies. This study investigates the role of HADHA, a key enzyme in fatty acid β-oxidation, in the progression of GBM. we show that the overexpression of HADHA in GBM correlates with a poor prognosis in patients and plays a role in promoting tumor growth and invasion. Mechanistically, HADHA regulates the JAK/STAT3 signaling pathway through modulation of H3K27ac histone acetylation. Knockdown of HADHA results in decreased acetyl-CoA levels, leading to reduced H3K27ac modification and subsequent inhibition of JAK/STAT3 activation. Furthermore, we show that the small molecule JIB-04, which targets HADHA, inhibits GBM cell proliferation and invasion both in vitro and in vivo. Our findings highlight the importance of targeting metabolic enzymes in cancer therapy and suggest that HADHA could represent a potential new therapeutic target for GBM. By targeting the metabolic-epigenetic pathway, this strategy presents a promising approach for treating this devastating disorder.https://doi.org/10.1038/s41420-025-02660-0
spellingShingle Kan Wang
Yifei Xiao
Jinxin Wan
Yuanqi Chu
Ruipeng Zheng
Fengjun Lv
Guang Yang
Mingchun Yang
Haitao Ge
Yuwen Song
Yu Cheng
HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
Cell Death Discovery
title HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
title_full HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
title_fullStr HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
title_full_unstemmed HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
title_short HADHA-mediated regulation of JAK/STAT3 signaling in glioblastoma: a metabolic-epigenetic axis
title_sort hadha mediated regulation of jak stat3 signaling in glioblastoma a metabolic epigenetic axis
url https://doi.org/10.1038/s41420-025-02660-0
work_keys_str_mv AT kanwang hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT yifeixiao hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT jinxinwan hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT yuanqichu hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT ruipengzheng hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT fengjunlv hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT guangyang hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT mingchunyang hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT haitaoge hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT yuwensong hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis
AT yucheng hadhamediatedregulationofjakstat3signalinginglioblastomaametabolicepigeneticaxis